Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Asian Journal of Andrology ; (6): 162-168, 2020.
Artículo en Inglés | WPRIM | ID: wpr-1009742

RESUMEN

Prostate cancer (PCa) exhibits epidemiological and molecular heterogeneity. Despite extensive studies of its phenotypic and genetic properties in Western populations, its molecular basis is not clear in Chinese patients. To determine critical molecular characteristics and explore correlations between genomic markers and clinical parameters in Chinese populations, we applied an integrative genetic/transcriptomic assay that combines targeted next-generation sequencing and quantitative real-time PCR (qRT-PCR) on samples from 46 Chinese patients with PCa. Lysine (K)-specific methyltransferase 2D (KMT2D), zinc finger homeobox 3 (ZFHX3), A-kinase anchoring protein 9 (AKAP9), and GLI family zinc finger 1 (GLI1) were frequently mutated in our cohort. Moreover, a clinicopathological analysis showed that RB transcriptional corepressor 1 (RB1) deletion was common in patients with a high risk of disease progression. Remarkably, four genomic events, MYC proto-oncogene (MYC) amplification, RB1 deletion, APC regulator of WNT signaling pathway (APC) mutation or deletion, and cyclin-dependent kinase 12 (CDK12) mutation, were correlated with poor disease-free survival. In addition, a close link between KMT2D expression and the androgen receptor (AR) signaling pathway was observed both in our cohort and in The Cancer Genome Atlas Prostate Adenocarcinoma (TCGA-PRAD) data. In summary, our results demonstrate the feasibility and benefits of integrative molecular characterization of PCa samples in disease pathology research and personalized medicine.


Asunto(s)
Adulto , Anciano , Humanos , Masculino , Persona de Mediana Edad , Proteínas de Anclaje a la Quinasa A/genética , Biomarcadores de Tumor/genética , China , Proteínas del Citoesqueleto/genética , Proteínas de Unión al ADN/genética , Amplificación de Genes , Secuenciación de Nucleótidos de Alto Rendimiento , Proteínas de Homeodominio/genética , Mutación , Proteínas de Neoplasias/genética , Neoplasias de la Próstata/patología , Proto-Oncogenes Mas , Receptores Androgénicos/genética , Transducción de Señal/genética , Proteína con Dedos de Zinc GLI1/genética
2.
Asian Journal of Andrology ; (6): 608-614, 2018.
Artículo en Inglés | WPRIM | ID: wpr-1009635

RESUMEN

The autonomic nervous system contributes to prostate cancer proliferation and metastasis. However, the exact molecular mechanism remains unclear. In this study, muscarinic acetylcholine receptor M1 (CHRM1) expression was measured via immunohistochemical analysis in human prostate cancer tissue array slides. PC-3, LNCaP, and A549 cells were treated with pirenzepine or carbachol, and the cell migration and invasion abilities were evaluated. Western blotting and quantitative real-time PCR were performed to measure GLI family zinc finger 1 (GLI1), patched 1 (PTCH1), and sonic hedgehog (SHH) expression levels. High expression of CHRM1 was found in early-stage human prostate cancer tissues. In addition, the selective CHRM1 antagonist pirenzepine inhibited PC-3, LNCaP, and A549 cell migration and invasion, but the agonist carbachol promoted the migration and invasion of these three cell lines. Muscarinic signaling can be relayed by hedgehog signaling. These data show that CHRM1 is involved in the regulation of prostate cancer migration and invasion through the hedgehog signaling pathway.


Asunto(s)
Humanos , Masculino , Carbacol/farmacología , Movimiento Celular/genética , Proliferación Celular , Proteínas Hedgehog/genética , Agonistas Muscarínicos/farmacología , Antagonistas Muscarínicos/farmacología , Receptor Patched-1/genética , Pirenzepina/farmacología , Neoplasias de la Próstata/patología , Receptor Muscarínico M1/genética , Proteína con Dedos de Zinc GLI1/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA